Opioid addiction agonist therapy and the QT prolongation phenomenon: state of the science and evolving research questions

Authors


  • Disclaimer: The views expressed in this editorial reflect the opinions of the authors only, and not the official policy of the Uniformed Services University, USA or the Department of Defense, USA.

No abstract is available for this article.

Ancillary